2020 4th International
Forum on Medical Innovation of
Cell & Bio Therapy
Open Innovation for Advanced Biomedical Science
Friday. Nov 27. 2020 10 AM (GMT+9)Webinar
사전등록 및 설문조사 완료 시 초록집 무료제공
Foundation for Medical Innovation (FMI) is a non-profit corporation approved by the Ministry of Science & ICT (MSIT) and established in 2016 for the purpose of investing the promising technologies and research trends that will lead the future medicine/life science for timely supply and effective spread of the latest treatment technique.
Session Program
─ Friday. Nov 27. 2020 10 AM (GMT+9)
AMResearch-centered Startup Support
ㅡ
ㅡ
Allocate Time |
Duration of time Presentation / Question |
Agenda |
Speaker |
Affiliation |
10:00 – 10:05 |
5' |
Opening Remarks |
Hyo-Soo Kim |
M.D., Ph.D. FAHA(Director, Strategic Center of CBT (Cell & Bio Therapy) for Heart, Diabetes, & Cancer, Korea) |
10:05 – 10:10 |
5' |
Welcoming Remarks |
Sang-Dae Han |
Chairman (Foundation for Medical Innovation, Korea) |
10:10 – 10:35 |
20'/5' |
Acceleration of Biotherapeutics R&D through OSONG New Drug Development Center |
Tae-Gyu Lee |
Head of New Drug Development Support Center (OSONG Medical Innovation Foundation, Korea) |
10:35 – 11:00 |
20'/5' |
Bio Health Startup Government Policy Trends and Implications |
Hyun-Chul Kim |
Director of R&D Strategy (Korea Health Industry Development Institute, Korea) |
11:00 – 11:25 |
20'/5' |
Post Corona. Are the Rules of Happiness Changing? |
Kyung-Il Kim |
Professor (Ajou University, Korea) |
11:25 – 11:50 |
20'/5' |
How Best Social-Impact Investing Can Boost Biomedical R/D? |
Bekay Ahn |
CFRE, CPAE (International Council for Nonprofit Management, Korea) |
11:50 – 13:00 |
70' |
Lunch |
|
|
PMMedical Technology Innovations
ㅡ
ㅡ
Allocate Time |
Duration of time Presentation / Question |
Agenda |
Speaker |
Affiliation |
13:00 – 13:25 |
25' |
Somatic Mosaicism, Clonal Hematopoiesis and Vascular Diseases |
Kenneth Walsh |
Ph.D. (University of Virginia, USA) |
13:25 – 13:50 |
25' |
Lifestyle Effects on Inflammation and Cardiovascular Disease |
Filip K. Swirski |
Ph.D. (Harvard University, USA) |
13:50 – 14:20 |
30' |
Direct Transplantation of HLA-haplotype Homo iPS Cell-Derived Purified Ventricular Cardiomyocytes for the Treatment of Patients with HFrEF |
Keiichi Fukuda |
M.D., Ph.D. (Keio University School of Medicine, Japan) |
14:20 – 14:25 |
5' |
Coffee Break |
|
|
14:25 – 14:45 |
20' |
COVID-19 and Cardiovascular Disease |
Kyung-Woo Park |
M.D., Ph.D. (Seoul National University Hospital, Korea) |
14:45 – 15:10 |
20'/5' |
AI for Biomedical Sciences |
Byoung-Tak Zhang |
Ph.D. (AI Institute, Seoul National University, Korea) |
15:10 – 15:30 |
20' |
Novel Biological Function of Lymphatic Vessels |
Gou-Young Koh |
M.D., Ph.D. (KAIST, Korea) |
15:30 – 15:35 |
5' |
Closing Remarks |
Hyo-Soo Kim |
M.D., Ph.D. FAHA(Director, Strategic Center of CBT (Cell & Bio Therapy) for Heart, Diabetes, & Cancer) |